Natural low-calorie sweeteners take centre stage amid shifting consumer health priorities

Natural low-calorie sweeteners take centre stage amid shifting consumer health priorities

Industry News
Trends

Cargill and ADM lead a surge in natural, low-calorie sweeteners driven by health trends, clean labelling, and the rise of weight management medications, transforming product innovation in the food sector.

The evolving landscape of consumer preferences is driving a significant shift in product innovation within the food and beverage sector, with global ingredient giants Cargill and Archer Daniels Midland (ADM) at the forefront of advancing natural, low-calorie sweeteners. This movement is being propelled by an intersection of trends emphasising sugar reduction, clean labelling, and functional nutrition, reflecting consumers' complex demands for both health benefits and natural ingredient transparency.

Consumers today no longer see sugar reduction in isolation. According to Cargill, many expect their food and drinks not only to be lower in sugar but also to provide added nutritional value, such as protein or fibre, while being free from artificial ingredients without sacrificing taste. ADM's proprietary research supports this, revealing that a striking 83% of global consumers are actively limiting sugar intake, with 62% of North Americans specifically seeking low-calorie options. This widespread demand is also influenced by the rising use of anti-obesity medications, including GLP-1 receptor agonists like Ozempic and Mounjaro, among which 57% of users monitor sugar content more closely and express a willingness to pay a premium for reduced-sugar products.

The willingness to invest more in products carrying claims such as “naturally sweetened” or “no artificial sweeteners” indicates a growing consumer preference for clean labels, especially in North America where this concern amplifies the importance of sugar reduction by 61%, ADM reports. Recognisable, plant-derived sweeteners like stevia and agave are particularly favoured for their “closer-to-nature” appeal. This preference fuels a surging interest in mid-calorie beverages, which are experiencing double-digit growth, positioning sugar reduction as part of a nuanced spectrum rather than an all-or-nothing choice.

Both Cargill and ADM are capitalising on stevia-based sweeteners as key solutions in this dynamic market. Stevia's high sweetness level, 250 to 300 times that of sugar, combined with its low glycemic impact, makes it attractive in health-conscious formulations. Cargill's EverSweet, developed via a fermentation process through a joint venture with DSM called Avansya, uses less bitter steviol glycosides Reb B and Reb D to replicate sugar’s taste more closely. This fermentation-based production not only enhances flavour but also reduces exposure to agricultural and supply chain uncertainties. EverSweet has achieved GRAS status from the US FDA and positive safety assessments in Europe and the UK, reinforcing its market viability.

Meanwhile, ADM's recent launch of SweetRight Stevia Edgility reflects scientific and agronomic advancements that improve on traditional stevia extracts. By breeding superior stevia plant varietals and utilising enzyme technologies, ADM has achieved a sweetener profile with increased efficacy, reduced bitterness, and better cost management, directly addressing formulators’ challenges in achieving taste and label clean lines.

The broader market context emphasises the strategic importance of these innovations, particularly in regions like Latin America, where consumer preference for plant-based, low glycemic sweeteners such as stevia, agave, and monk fruit is driving the sweetener market to a projected 31% share by 2025. This aligns with sustainability goals and health-driven food reformulation trends that companies like Cargill and ADM are actively targeting.

As the marketplace becomes increasingly crowded, brands must not only deliver on health and clean label promises but also ensure enjoyable taste to secure repeat purchases. These shifts signal a tantalising challenge for product developers, blending nutrition science, flavour technology, and consumer insight to meet the expectations of a health-conscious public that values authenticity and enhanced functionality.

Looking ahead, the intersection between sugar reduction and the broader health trends propelled by pharmaceuticals like GLP-1 receptor agonists suggests an evolving role for food innovation in supporting weight management and holistic well-being. Industry players and researchers are actively exploring how reformulation, appetite suppression, and satiety science can be integrated into the food ecosystem, further expanding opportunities for natural, low-calorie sweeteners to play a critical role.